5 reports

Its products include in-vitro diagnostic (IVD) makers, reagents, microtiter plate ELISA testing devices, turbidimetric reagents, rapid testing and bioblot assay products, and HIV and HCV confirmatory devices.

  • Protein Therapy
  • Spain
  • United States
  • Supply
  • Biokit S.A.

As such, confirmatory immunoblot tests are administered to patients who test positively for HCV infection, and patients who test negatively but are at a high risk of having a false-negative result are tested again.

  • Protein Therapy
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • Roche Group

HCV VIRAL LOAD TEST - PROTEASE INHIBITOR (RG##) HCV VIRAL LOAD TEST - PROTEASE INHIBITOR (RG##) PRODUCT OVERVIEW HCV VIRAL LOAD TEST - PROTEASE INHIBITOR (RG##) - PRODUCT STATUS Market Category Developed By Pipeline Territory Highest Stage

  • Anti-Infective
  • Diagnostics
  • Infectious Disease
  • Protein Therapy
  • Targeted Therapy

Further, while HCV genotypes ## and ## make up the majority of HCV infections, other trials have shown similarly positive results with the short eight-week course when testing glecaprevir-pibrentasvir in genotypes ##, ##, ## and ##.

  • Hepatitis
  • Protein Therapy
  • Research And Development
  • Therapy
  • Bristol-Myers Squibb Company

IT IS A HCV INFECTIVITY INHIBITOR ## (HCV II-##).

  • Antiviral
  • Hepatitis
  • Pharmaceutical
  • Protein Therapy
  • Therapy